findmyKOL
Clinical trialNCT06427954RecruitingInterventional

Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

SponsorMassachusetts General HospitalEnrollment250Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California Los Angeles

    Los Angeles, California, United States

    Recruiting
  • Veteran Affairs Greater Los Angeles Health Care

    Los Angeles, California, United States

    Not, yet, recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Jennifer Temel, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Aug 2024
Primary completion
30 Sept 2027
Completion
31 Dec 2027
Last update posted
13 Jul 2026
Registered enrollment
250
Registry id
NCT06427954

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.